ArticleResearch and practice in thrombosis and haemostasis2019

Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia A.

Pratima Chowdary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.